Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Atropine (0.01%, 0.02%, 0.03%) for Myopia in Children
NCT03699423Phase 1Completed
- Sponsor
- Hai Yen Eye Care
- Start
- Mar 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised trial of NVK002 in myopia (3 arms), sponsored by Hai Yen Eye Care. Primary endpoints: Change in pupillary diameter at 2 weeks and Change in accommodative amplitude at 2 weeks. Started Mar 2018; status: completed.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT03699423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03699423.